Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The primary objectives of the study is to evaluate the effectiveness and safety of
glufosfamide in subjects with pancreatic cancer who have been previously treated with
gemcitabine as measured by overall survival compared with best supportive care.